Pfizer Inks $164M Settlement In Celebrex Securities Suit
Pfizer Inc. agreed Friday to pay $164 million to settle a certified securities fraud class action in New Jersey federal court alleging it made materially false statements about a clinical study...To view the full article, register now.
Already a subscriber? Click here to view full article